2022

    1. Stenman C, Abrahamsson E, Redsäter M, Gnanapragasam VJ, Bratt O. Rates of Positive Abdominal Computed Tomography and Bone Scan Findings Among Men with Cambridge Prognostic Group 4 or 5 prostate cancer: A Nationwide Registry Study.  Eur Urol Open Sci. 2022 Jun. Sammanfattning
    2. Balabanova Y, Farahmand B, Garmo H, Stattin P, Brobert G. Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden. BMJ Open. 2022 May. Sammanfattning.
    3. Klein RJ, Vertosick E, Sjoberg D, Ulmert D, Rönn AC, Häggström C, Thysell E, Hallmans G, Dahlin A, Stattin P, Melander O, Vickers A, Lilja H. Prostate cancer polygenic risk score and prediction of lethal prostate cancer. NPJ Precis Oncol. 2022 Apr. Sammanfattning. Fulltext
    4. Jochems SHJ, Haggstrom C, Stattin P, Järvholm B, Stocks T. Association of blood pressure with prostate cancer risk by disease severity, and prostate cancer death: a pooled cohort study. Cancer Epidemiol Biomarkers Prev. 2022 May 5. Sammanfattning.
    5. Jochems SHJ, Fritz J, Häggström C, Järvholm B, Stattin P, Stocks T. Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study. Eur Urol. 2022 May. Sammanfattning. Fulltext
    6. Braide K, Kindblom J, Thellenberg Karlsson C, Stattin P, Hugosson J, Månsson M. Risk of severe late toxicity after radiotherapy following radical prostatectomy – a nationwide study. BJU Int. 2022 May. Sammanfattning.
    7. Bonde TM, Westerberg M, Aly M, Eklund M, Adolfsson J, Bill-Axelson A, Garmo H, Stattin P, Robinson D. Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists. Scandinavian Journal of Urology 2022 May. Sammanfattning. Fulltext
    8. Van Hemelrijck M, Ventimiglia E, Robinson D, Gedeborg R, Holmberg L, Stattin P, Garmo H. Population-based estimates of age and comorbidity specific life expectancy: a first application in Swedish males. BMC Medical Informatics and Decision Making 2022 Feb. Sammanfattning. Fulltext
    9. Alverbratt C, Vikman H, Hjälm Eriksson M, Stattin P, Franck Lissbrant I. Time difference in retrieving clinical information in Patient-overview Prostate Cancer compared to electronic health records. Scand J Urol. 2022 Feb. Sammanfattning. Fulltext
    10. Balabanova Y, Farahmand B, Stattin P, Garmo H, Brobert G. Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden. BMC Urology. 2022 Feb. SammanfattningFulltext
    11. Gedeborg R, Garmo H, Thellenberg-Karlsson C, Fallara G, Styrke J, Franck Lissbrant I, Stattin P. Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study. Acta Oncol. 2022 Jan. Sammanfattning. Fulltext